List of 2022 Speakers


2022 Conference Speakers



Confirmed Speakers Joining Us in 2022:
Mira Chaurushiya, Senior Partner, Westlake Village BioPartners
Marianne De Backer,
PhD, MBA, EVP Global Head, Strategy & Business Development, Bayer
Janeen Doyle,
VP, Head of Research & Early Dev Alliance Management, Bristol-Myers Squibb
Jessica Droge,
Vice President. Business Development, Amgen 
Dan Estes,
General Partner, Frazier Healthcare Partners
Stephen C. Ferrulo,
Partner, Perkins Coie
Rusty Gage,
President, Salk Institute
Carol Gallagher, Pharm.D., Venture Partner, NEA
Kevin Grimes, 
Professor of Chemical and Systems Biology; Co-director of the SPARK Program at Stanford University School of Medicine
Jeff Guise, Partner, Evershed Sutherland
Jason Hafler,
Managing Director, Sanofi Ventures
Jeff Hatfield,
CEO, Vividion 
Grace Han McMahon,
AVP and Head, Pacific Business Development and Licensing, Merck
Katie Hewitt,
Chief Business Officer, Lilly New Ventures, Eli Lilly & Company
Richard Heyman,
Ph.D., Venture Partner, Arch Ventures; Founder and Executive Chairman of the Board, Metacrine Inc.
Mike Jung,
Distinguished Professor of Chemistry, UCLA
Chau Khuong, Private Equity Partner, OrbiMed Advisors
Jim Krenn, Partner, Morrison & Foerster LLP
Cheston Larson,
Partner, Latham & Watkins
Scott Lippman,
Director, Moores Cancer Center, UC San Diego Health
Stefan Luzi, Partner, Gilde Healthcare
Shyam Masrani, Principal, Medicxi
Chris Nardo, Managing Director, Life Sci Partners
Carole Nuechterlein,
Head, Roche Venture Fund
Joe Panetta, President and CEO, Biocom California
Scott Platshon,
Partner, EcoR1
Camille Samuels,
Partner, Venrock
Stephanie Siroto,
Partner, RTW Investments LP
Lesley Stolz, PhD,
Regional Vice President, Early Innovation Partnering, Johnson & Johnson Innovation
Avi Spier, PhD.,
Executive Director, Search & Evaluation, NIBR BD&L, Novartis Institutes for BioMedical Research
Jay Stamatis, Vice President, Head of Business Development and Acquisitions, AbbVie
Matt Tremblay, Chief Operating Officer, The Scripps Research Institute & Calibr
Jeffrey Warmke,
Ph.D, Senior Vice President, Search and Evaluation & Alliance Management, Global Business Development, Daiichi Sankyo
John Wehrli,
Partner, Wilson Sonsini
Asish Xavier,
J&J Innovation, JJDC, Vice President, Venture Investments, Johnson & Johnson